Breast Cancer-Targets and Therapy is a leading journal in the field of oncology, published by DOVE MEDICAL PRESS LTD in New Zealand. Established as an Open Access journal in 2009, it offers a platform for researchers and healthcare professionals to disseminate innovative findings and therapeutic strategies related to breast cancer. With an impressive ranking in the Q2 category of oncology journals as of 2023, and placed at Rank #203/404 in the Scopus database, this journal facilitates the exchange of high-quality research aimed at improving patient outcomes and advancing clinical practices. Covering a wide array of topics from basic research to clinical trials, Breast Cancer-Targets and Therapy plays a crucial role in bridging the gap between scientific discovery and practical application. Researchers, professionals, and students alike will find the journal a valuable resource for the latest advancements and best practices in breast cancer treatment.

GEBURTSHILFE UND FRAUENHEILKUNDE is a prestigious journal dedicated to the fields of Maternity, Midwifery, Obstetrics, and Gynecology, published by GEORG THIEME VERLAG KG, a reputable publisher known for its commitment to advancing medical knowledge. Established in 1947, the journal has consistently provided a platform for high-quality research and clinical studies that address current challenges and innovations in women's health. With an impact factor positioned in Q2 for Maternity and Midwifery and Q3 in Obstetrics and Gynecology, it ranks among the top journals within its field, further solidified by its Scopus rankings highlighting its influential presence. Although the journal is not open access, it remains an essential resource for academics and practitioners keen to stay informed on the latest evidence-based practices and cutting-edge research, ensuring that all stakeholders in women's healthcare can access critical insights to enhance patient outcomes.

Aesthetic Surgery Journal is a premier, peer-reviewed publication that serves as a vital platform for advancing the field of aesthetic surgery. Published by Oxford University Press Inc., this esteemed journal holds a remarkable reputation, evidenced by its Q1 rankings in both Medicine (miscellaneous) and Surgery categories as of 2023, placing it within the top percentile in Scopus rankings (#41 out of 551) for the specialty. With an ISSN of 1090-820X and an E-ISSN of 1527-330X, the journal has been contributing to the scholarly dialogue since 1995, and it continues to shape the future of aesthetic practices through rigorous research, innovative techniques, and critical reviews. Its scope encompasses the latest developments in surgical procedures, patient safety, and technological advances in aesthetics, making it an essential resource for surgeons, researchers, and students aiming to enhance their expertise and understanding in this dynamic field. While the journal does not offer open access, it remains accessible through various academic libraries worldwide, ensuring that the latest findings reach the hands of those committed to excellence in aesthetic surgery.

Journal of Breast Imaging is an esteemed peer-reviewed journal dedicated to advancing the field of breast imaging, published by Oxford University Press. Since its inception in 2019, the journal has been instrumental in disseminating innovative research and clinical practices, contributing vital knowledge to the domains of Radiology, Nuclear Medicine, and Ultrasound Technology. Notably, it holds a respectable impact factor and is categorized in the Q2 quartile for both applicable categories, asserting its position as a significant resource within the scholarly community. With a commendable ranking of #153/333 in Radiology, and #31/63 in Radiological and Ultrasound Technology, the journal consistently showcases groundbreaking studies that influence best practices and set a benchmark for practitioners and researchers alike. Although it currently does not offer open access, the journal prioritizes high-quality research that is pivotal for understanding and enhancing breast imaging methodologies at a global level. By exploring topics that range from the latest imaging techniques to innovative diagnostic technologies, the Journal of Breast Imaging serves as a cornerstone for professionals seeking to enhance their knowledge and expertise in this vital area of health care.

The Journal of Plastic Surgery and Hand Surgery, published by Medical Journal Sweden AB, stands as a significant resource in the field of surgical medicine, focusing on advancements and innovations in both plastic and hand surgery. With an ISSN of 2000-656X and an E-ISSN of 2000-6764, this journal is committed to disseminating high-quality, peer-reviewed research that reflects the latest trends and practices within the specialty. Operating under an Open Access model, the journal ensures that critical information is readily available to a global audience, enhancing collaboration and knowledge exchange among professionals and researchers. The journal boasts an impressive Scopus rank, sitting at #258 out of 551 in the medicine and surgery category, positioning itself within the 53rd percentile and further solidifying its influence in the medical community. As it converges its scope from 2010 to 2024, contributors are encouraged to elaborate on pioneering methods, the intricacies of surgical techniques, and the evolving landscape of patient care. The Journal of Plastic Surgery and Hand Surgery is more than just a publication; it is a platform dedicated to fostering dialogue and advancements in the vital field of surgery.

Current Breast Cancer Reports is a vital academic journal published by Springer that focuses on the latest research and advancements in the field of breast cancer. With its ISSN 1943-4588 and E-ISSN 1943-4596, this journal serves as an essential resource for oncologists, researchers, and healthcare professionals dedicated to improving diagnosis and treatment strategies for breast cancer. Spanning from 2009 to 2024, it provides a platform for high-quality, peer-reviewed articles that encompass a range of topics, including molecular biology, clinical trials, and innovative therapeutic approaches. Although it is currently classified in the Q3 category in Oncology and is positioned in the 29th percentile, the journal remains committed to elevating its academic impact and contributing meaningfully to the ongoing fight against breast cancer. As it seeks to disseminate critical findings and foster collaboration within the scientific community, Current Breast Cancer Reports is poised to be an indispensable tool for anyone keen on advancing the field.

Journal of Breast Cancer, published by the Korean Breast Cancer Society, stands as a pivotal platform for disseminating groundbreaking research and advancements in the field of breast cancer. With an ISSN of 1738-6756 and an E-ISSN of 2092-9900, this open-access journal has been a vital resource since 1998, ensuring that important findings are accessible to all. The journal is situated in South Korea, at 163 Sinmunro 1-ga Jongro-gu, Official Building, Suite 2024, Seoul 110-999, South Korea, fostering an international exchange of knowledge within the scientific community. As a leader in oncology and cancer research, it is categorized in the Q3 quartile for both fields as of 2023, with Scopus rankings reflecting its influence and reach. Researchers and clinicians alike benefit from its rigorous peer-review process and diverse array of articles, which cover the latest studies, treatment strategies, and clinical trials. The Journal of Breast Cancer plays an essential role in shaping future research directions and improving patient outcomes in breast cancer care, making it an invaluable resource for all stakeholders in the oncology field.

Current Problems in Cancer: Case Reports is a prominent scholarly journal published by Elsevier, focusing on critical case reports within the field of oncology. Since its transition to Open Access in 2020, it has enhanced accessibility for researchers and healthcare professionals seeking to share and discuss unique clinical scenarios and insights that advance cancer treatment and patient care. Operating from the United States, this journal aims to address the important and often intricate challenges faced in oncology, facilitating a platform for knowledge exchange and the exploration of new perspectives in cancer management. Despite its current Q4 category ranking in the 2023 oncology category of Scopus with a rank of #359/404, its goal is to enrich the academic discourse by featuring diverse case reports and promoting evidence-based practices. As the journal evolves from 2021 to 2024, it seeks to impact the field by inviting researchers, professionals, and students to contribute their findings, ultimately fostering a collaborative environment for tackling the complexities of cancer.

Gland Surgery, an esteemed journal published by AME PUBLISHING COMPANY, is at the forefront of surgical research, particularly focusing on advancements in gland-related surgeries and their clinical implications. With an ISSN of 2227-684X and an E-ISSN of 2227-8575, this open-access journal provides a platform for disseminating high-quality research and insights into the intricate aspects of surgical practices, ranking in the Q2 category in Surgery as of 2023. As evidenced by its Scopus ranking at #153 out of 551 in the Medicine_Surgery field, Gland Surgery delivers valuable contributions to the global medical community, promoting the exchange of knowledge and innovative techniques. Operating from Hong Kong, China, and converging its excellence from 2016 to 2024, the journal is a critical resource for researchers, clinicians, and students keen on exploring the latest developments in the field. By fostering an open dialogue among professionals, Gland Surgery is accessible to a diverse audience seeking to enhance their understanding and practice in gland surgery.

Breast Cancer-Basic and Clinical Research is a premier open access journal published by SAGE Publications Ltd, dedicated to advancing the understanding and treatment of breast cancer through a comprehensive approach that integrates basic and clinical research findings. Since its inception in 2008, this journal has aimed to serve as a vital platform for researchers, healthcare professionals, and students in the fields of oncology and cancer research, providing them with timely access to significant new research, clinical trials, and innovative methodologies. With its current rankings placing it in the Q3 quartile for Cancer Research and Oncology, it reflects a steady commitment to quality and relevance, ranking #167/404 in Medicine - Oncology and #133/230 in Biochemistry, Genetics and Molecular Biology - Cancer Research as of 2023. The journal is designed to foster dialogue and collaboration across disciplines, enabling advancements in therapeutic strategies and patient care. Researchers and professionals will find it an invaluable resource as it continues to push the frontiers of knowledge in breast cancer research.